SEARCH

SEARCH BY CITATION

References

  • Adam-Klages S., Schwandner R., Adam D., Kreder D., Bernardo K. and Kronke M. (1998) Distinct adapter proteins mediate acid versus neutral sphingomyelinase activation through the p55 receptor for tumor necrosis factor. J. Leukoc. Biol. 63, 678682.
  • Appelgren A., Appelgren B., Kopp S., Lundeberg T. and Theodorsson E. (1993) Relation between intra-articular temperature of the arthritic temporomandibular joint and presence of calcitonin gene-related peptide in the joint fluid. A clinical study. Acta Odontol. Scand. 51, 285291.
  • Appelgren A., Appelgren B., Kopp S., Lundeberg T. and Theodorsson E. (1995) Neuropeptides in the arthritic TMJ and symptoms and signs from the stomatognathic system with special considerations to rheumatoid arthritis. J. Orofac. Pain 9, 215225.
  • Barbin G., Roisin M. and Zalc B. (2001) Tumor necrosis factor α activates the phosphorylation of ERK, SAPK/JNK, and P38 kinase in primary cultures of neurons. Neurochem. Res. 26, 107112.
  • Barker V., Middleton G., Davey F. and Davies A. (2001) TNFα contributes to the death of NGF-dependent neurons during development. Nat. Neurosci. 4, 11941198.
  • Bolay H., Reuter U., Dunn A., Huang Z., Boas D. and Moskowitz M. (2002) Intrinsic brain activity trigger trigeminal meningeal afferents in a migraine model. Nat. Med. 8, 136142.
  • Brain S., Williams T., Tippins J., Morris H. and MacIntyre I. (1985) Calcitonin gene-related peptide is a potent vasodilator. Nature 313, 5456.
  • Bruce A., Boling W., Kindy M., Peschon J., Kraemer P., Carpenter M., Holtsberg F. and Mattson M. (1996) Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nat. Med. 2, 788794.
  • DeBustros A., Baylin S., Levine M. and Nelkin B. (1986) Cyclic AMP and phorbol esters separately induce growth inhibition, calcitonin secretion, and calcitonin gene transcription in cultured human medullary thyroid carcinoma. J. Biol. Chem. 261, 80368041.
  • Buzzi M., Bonamini M. and Moskowitz M. (1995) Neurogenic model of migraine. Cephalalgia 15, 277280.
  • Cavaillon J. (2001) Pro- versus anti-inflammatory cytokines: myth or reality. Cell Mol. Biol. 47, 695702.
  • Chen G. and Goeddel D. (2002) TNF-R1 signaling: a beautiful pathway. Science 296, 16341635.
  • Chen W., West A., Tao X., Corfas G., Szentirmay M., Sawadogo M., Vinson C. and Greenberg M. (2003) Upstream stimulatory factors are mediators of Ca2+-responsive transcription in neurons. J. Neurosci. 23, 25722581.
  • Cheng B., Christakos S. and Mattson M. (1994) Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis. Neuron 12, 139153.
  • Covelli V., Munno I., Pellegrino N., Marinaro M., Gesario A., Massari F., Savastano S. and Jirillo E. (1992) In vivo administration of propranolol decreases exaggerated amounts of serum TNF-α in patients with migraine without aura. Possible mechanism of action. Acta Neurol. 14, 313319.
  • Cunha F., Poole S., Lorenzetti B. and Ferreira S. (1992) The pivotal role of tumour necrosis factor α in the development of inflammatory hyperalgesia. Br. J. Pharmacol. 107, 660664.
  • Durham P. and Russo A. (1998) Serotonergic repression of mitogen-activated protein kinase control of the calcitonin gene-related peptide enhancer. Mol. Endocrinol. 12, 10021009.
  • Durham P. and Russo A. (1999) Regulation of calcitonin gene-related peptide secretion by a serotonergic antimigraine drug. J. Neurosci. 19, 34233429.
  • Durham P. and Russo A. (2000) Differential regulation of mitogen-activated protein kinase-responsive genes by the duration of a calcium signal. Mol. Endocrinol. 14, 15701582.
  • Durham P. and Russo A. (2003) Stimulation of the calcitonin gene-related peptide enhancer by mitogen-activated protein kinases and repression by an antimigraine drug in trigeminal ganglia neurons. J. Neurosci. 23, 807815.
  • Durham P., Cady R. and Cady R. (2004a) Regulation of calcitonin gene-related peptide secretion from trigeminal nerve cells by botulinum toxin type A: implications for migraine therapy. Headache 44, 3542.
  • Durham P., Dong P., Belasco K., Kasperski J., Gierasch W., Edvinsson L., Heistad D., Faraci F. and Russo A. (2004b) Neuronal expression and regulation of CGRP promoter activity following viral gene transfer into cultured trigeminal ganglia neurons. Brain Res. 997, 103110.
  • Edvinsson L., Mulder H., Goadsby P. and Uddman R. (1998) Calcitonin gene-related peptide and nitric oxide in the trigeminal ganglion: cerebral vasodilation from trigeminal nerve stimulation involves mainly calcitonin gene-related peptide. J. Auton. Nerv. Syst. 70, 1522.
  • Empl M., Sostak P., Riedel M., Schwarz M., Muller N., Forderreuther S. and Straube A. (2003) Decreased sTNF-RI in migraine patients? Cephalalgia 23, 5558.
  • Falluel-Morel A., Aubert N., Vaudry D., Basille M., Fontaine M., Fournier A., Vaudry H. and Gonzalez B. (2004) Opposite regulation of the mitochondrial apoptotic pathway by C2-ceramide and PACAP through a MAP-kinase-dependent mechanism in cerebellar granule cells. J. Neurochem. 91, 12311243.
  • Fanciullacci M., Alessandri M., Figini M., Geppetti P. and Michelacci S. (1995) Increase in plasma calcitonin gene-related peptide from the extracerebral circulation during nitroglycerin-induced cluster headache attack. Pain 60, 119123.
  • Fu K., Ma X., Zhang Z. and Chen W. (1995) Tumor necrosis factor in synovial fluid of patients with temporomandibular disorders. J. Oral Maxillofac. Surg. 53, 424426.
  • Galibert M., Carreira S. and Goding C. (2001) The Usf-1 transcription factor is a novel target for the stress-responsive p38 kinase and mediates UV-induced tyrosinase expression. EMBO J. 20, 50225031.
  • Goadsby P. and Edvinsson L. (1993) The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann. Neurol. 33, 4856.
  • Goadsby P. and Edvinsson L. (1994) Human in vivo evidence for trigeminovascular activation in cluster headache. Neuropeptide changes and effects of acute attacks therapies. Brain 117, 427434.
  • Goadsby P., Lipton R. and Ferrari M. (2002) Migraine – current understanding and treatment. N. Engl. J. Med. 346, 257270.
  • Grell M., Douni E., Wajant H. et al. (1995) The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80-kDa tumor necrosis factor receptor. Cell 83, 793802.
  • Hanada T. and Yoshimura A. (2002) Regulation of cytokine signaling and inflammation. Cytokine Growth Factor Rev. 13, 413421.
  • Herbert M. and Holzer P. (1994) Interleukin-1β enhances capsaicin-induced neurogenic vasodilatation in the rat skin. Br. J. Pharmacol. 111, 681686.
  • Hopkins S. and Rothwell N. (1995) Cytokines and the nervous system. I: Expression and recognition. Trends Neurosci. 18, 8388.
  • Kacena M., Merrel G., Konda S., Wilson K., Xi Y. and Horowitz M. (2001) Inflammation and bony changes at the temporomandibular joint. Cells Tissues Organs 169, 257264.
  • Kayali A., Austin D. and Webster N. (2000) Stimulation of MAPK cascades by insulin and osmotic shock: lack of an involvement of p38 mitogen-activated protein kinase in glucose transport in 3T3-L1 adipocytes. Diabetes 49, 17831793.
  • Kemper R., Meijler W., Korf J. and Ter Horst G. (2001) Migraine and function of the immune system: a meta-analysis of clinical literature published between 1966 and 1999. Cephalalgia 21, 549557.
  • Kopp S. (2001) Neuroendocrine, immune, and local responses related to temporomandibular disorders. J. Orofac. Pain 15, 928.
  • Lanigan T. and Russo A. (1997) Binding of upstream stimulatory factor and a cell-specific activator to the calcitonin/calcitonin gene-related peptide enhancer. J. Biol. Chem. 272, 1831618324.
  • Li Y., Ji A., Weihe E. and Schafer M. (2004) Cell-specific expression and lipopolysaccharide-induced regulation of tumor necrosis factor α (TNFα) and TNF receptors in rat dorsal root ganglion. J. Neurosci. 24, 96239631.
  • Mori I., Goshima F., Koshizuka T. et al. (2003) Iba1-expressing microglia respond to herpes simplex virus infection in the mouse trigeminal ganglion. Brain Res. Mol. Brain Res. 120, 5256.
  • Nicolodi M. and Del Bianco E. (1990) Sensory neuropeptides (substance P, calcitonin gene-related peptide) and vasoactive intestinal polypeptide in human saliva: Their pattern in migraine and cluster headache. Cephalalgia 10, 3950.
  • Opree A. and Kress M. (2000) Involvement of the proinflammatory cytokines tumor necrosis factor-α, IL-1β, and IL-6 but not IL-8 in the development of heat hyperalgesia: effects on heat-evoked calcitonin gene-related peptide release from rat skin. J. Neurosci. 20, 62896293.
  • Palladino M., Bahjat F., Theodorakis E. and Moldawer L. (2003) Anti-TNF-α therapies: the next generation. Nat. Rev. Drug Discov. 2, 736746.
  • Parsons A. and Strijbos P. (2003) The neuronal versus vascular hypothesis of migraine and cortical spreading depression. Curr. Opin. Pharmacol. 3, 7377.
  • Perini F., D'Andrea G., Galloni E., Pignatelli F., Billo G., Alba S., Bussone G. and Toso V. (2005) Plasma cytokine levels in migraineurs and controls. Headache 45, 926931.
  • Pollock J., McFarlane S., Connell M., Zehavi U., Vandenabeele P., MacEwan D. and Scott R. (2002) TNF-α receptors simultaneously activate Ca2+ mobilisation and stress kinases in cultured sensory neurones. Neuropharmacology 42, 93106.
  • Rainero I., Pinessi L., Salani G., Valfre W., Rivoiro C., Savi L., Gentile S., Giudice R. and Grimaldi L. (2002) A polymorphism in the interleukin-1α gene influences the clinical features of migraine. Headache 42, 337340.
  • Rainero I., Grimaldi L., Salani G., Valfre W., Rivoiro C., Savi L. and Pinessi L. (2004) Association between the tumor necrosis factor-α-308 G/A gene polymorphism and migraine. Neurology 62, 141143.
  • Raingeaud J., Gupta S., Rogers J., Dickens M., Han J., Ulevitch R. and Davis R. (1995) Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J. Biol. Chem. 270, 7420–7426.
  • Reuter U., Bolay H., Jansen-Olesen I., Chiarugi A., Sanchez del Rio M., Letourneau R., Theoharides T., Waeber C. and Moskowitz M. (2001) Delayed inflammation in rat meninges: implications for migraine pathophysiology. Brain 124, 24902502.
  • Rothwell N. and Hopkins S. (1995) Cytokines and the nervous system II: Actions and mechanisms of action. Trends Neurosci. 18, 130136.
  • Sanlioglu S., Williams C., Samavati L., Butler N., Wang G., McCray P. J., Ritchie T., Hunninghake G., Zandi E. and Engelhardt J. (2001) Lipopolysaccharide induces Rac1-dependent reactive oxygen species formation and coordinates tumor necrosis factor-α secretion through IKK regulation of NF-κB. J. Biol. Chem. 276, 30 18830 198.
  • Schafers M., Svensson C., Sommer C. and Sorkin L. (2003) Tumor necrosis factor-α induces mechanical allodynia after spinal nerve ligation by activation of p38 MAPK in primary sensory neurons. J. Neurosci. 23, 25172521.
  • Schramek H. (2002) MAP kinases: from intracellular signals to physiology and disease. News Physiol. Sci. 17, 6267.
  • Sessle B. (2001) New insights into peripheral chemical mediators of temporomandibular pain and inflammation. J. Orofac Pain 15, 5.
  • Shinoda S., Skradski S., Araki T., Schindler C., Meller R., Lan J., Taki W., Simon R. and Henshall D. (2003) Formation of a tumour necrosis factor receptor 1 molecular scaffolding complex and activation of apoptosis signal-regulating kinase 1 during seizure-induced neuronal death. Eur. J. Neurosci. 17, 20652076.
  • Tabuchi A., Sakaya H., Kisukeda T., Fushiki H. and Tsuda M. (2002) Involvement of an upstream stimulatory factor as well as cAMP-responsive element-binding protein in the activation of brain-derived neurotrophic factor gene promoter I. J. Biol. Chem. 277, 35 92035 931.
  • Taylor P., Williams R. and Feldmann M. (2004) Tumour necrosis factor α as a therapeutic target for immune-mediated inflammatory diseases. Curr. Opin. Biotechnol. 15, 557563.
  • Thiagalingam A., DeBustros A., Borges M., Jasti R., Compton D., Diamond L., Mabry M., Ball D., Baylin S. and Nelkin B. (1996) RREB-1, a novel zinc finger protein, is involved in the differentiation response to ras in human medullary thyroid carcinomas. Mol. Cell Biol. 16, 53355345.
  • Tverberg L. and Russo A. (1993) Regulation of the calcitonin/calcitonin gene-related peptide gene by cell-specific synergy between helix-loop-helix and octamer-binding transcription factors. J. Biol. Chem. 268, 15 96515 973.
  • Vaughan W. (1927) Allergic migraine. J. Am. Med. Assoc. 88, 13831386.
  • Viney T., Schmidt T., Gierasch W., Sattar A., Yaggie R., Kuburas A., Quinn J., Coulson J. and Russo A. (2004) Regulation of the cell-specific calcitonin/calcitonin gene-related peptide enhancer by USF and the Foxa2 forkhead protein. J. Biol. Chem. 279, 4994849955.
  • Vitkovic L., Bockaert J. and Jacque C. (2000) ‘Inflammatory’ cytokines: neuromodulators in normal brain? J. Neurochem. 74, 457471.
  • Williamson D. and Hargreaves R. (2001) Neurogenic inflammation in the context of migraine. Microsc. Res. Tech. 53, 167178.